JFG
CATX icon

JDM Financial Group’s Perspective Therapeutics CATX Stock Holding History

JDM Financial Group’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Hold
3,500
– – ﹤0.01% 197
2026
Q1 		$14.6K Hold
3,500
– – 0.01% 164
2025
Q4 		$9.63K Hold
3,500
– – ﹤0.01% 188
2025
Q3 		$12K Hold
3,500
– – 0.01% 176
2025
Q2 		$12K Hold
3,500
– – 0.01% 164
2025
Q1 		$7.46K Hold
3,500
– – ﹤0.01% 195
2024
Q4 		$11.2K Hold
3,500
– – 0.01% 173
2024
Q3 		$46.7K Sell
3,500
-31,500
-90% -$419K 0.03% 92
2024
Q2 		$37.5K Buy
35,000
+31,500
+900% +$455K 0.03% 92
2024
Q1 		$41.6K Hold
3,500
– – 0.03% 81
2023
Q4 		$14.1K Hold
3,500
– – 0.01% 115
2023
Q3 		$9.58K Hold
3,500
– – 0.01% 127
2023
Q2 		$23.4K Hold
3,500
– – 0.02% 95
2023
Q1 		$22.3K Hold
3,500
– – 0.02% 97
2022
Q4 		$8.65K Buy
+3,500
New +$11.5K 0.01% 140

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

JDM Financial Group's CATX Position: Q2 2026 in Review

JDM Financial Group held its Perspective Therapeutics (CATX) position steady in Q2 2026 at 3,500 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #197.

JDM Financial Group first reported a position in CATX in Q4 2022 and has held it in 15 quarters since. The position peaked at $46.7K in Q3 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • JDM Financial Group held 3,500 shares of Perspective Therapeutics worth $11.9K as of Q2 2026.
  • JDM Financial Group left its Perspective Therapeutics share count unchanged in Q2 2026.
  • Perspective Therapeutics made up ﹤0.01% of JDM Financial Group's portfolio in Q2 2026, its #197 holding.
  • JDM Financial Group first reported a position in Perspective Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • JDM Financial Group's Perspective Therapeutics position peaked at $46.7K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on JDM Financial Group's 13F filing for Q2 2026, filed 18 Aug 2026.